Renalytix AI (RNLX)
(Real Time Quote from BATS)
$0.30 USD
0.00 (0.44%)
Updated Jul 23, 2024 10:48 AM ET
2-Buy of 5 2
F Value B Growth B Momentum D VGM
Price, Consensus and EPS Surprise
RNLX 0.30 0.00(0.44%)
Will RNLX be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for RNLX based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for RNLX
New Strong Buy Stocks for October 26th
What Makes Renalytix AI PLC Sponsored ADR (RNLX) a New Strong Buy Stock
RNLX: What are Zacks experts saying now?
Zacks Private Portfolio Services
New Strong Buy Stocks for October 12th
Renalytix AI PLC Sponsored ADR (RNLX) Loses -44.61% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Momentive (MNTV) Surges 10.1%: Is This an Indication of Further Gains?
Other News for RNLX
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
Renalytix AI’s KidneyIntelX Gains Medicare Coverage Approval
Medicare Issues Final Coverage Determination for kidneyintelX.dkd
Renalytix announces Medicare issued coverage determination for kidneyintelX.dkd